Download | < Back |
31 Mar 2016 | |
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated March 31, 2016, titled "Dr. Reddys Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai".<BR> | |
View all announcements for DR.REDDY'S LABORATORIES LTD. | Source: BSE India |